WO2004097419A1 - Membrane strip biosensor system for point-of-care testing - Google Patents
Membrane strip biosensor system for point-of-care testing Download PDFInfo
- Publication number
- WO2004097419A1 WO2004097419A1 PCT/KR2004/000914 KR2004000914W WO2004097419A1 WO 2004097419 A1 WO2004097419 A1 WO 2004097419A1 KR 2004000914 W KR2004000914 W KR 2004000914W WO 2004097419 A1 WO2004097419 A1 WO 2004097419A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- membrane
- pad
- signal
- enzyme
- detection
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60J—WINDOWS, WINDSCREENS, NON-FIXED ROOFS, DOORS, OR SIMILAR DEVICES FOR VEHICLES; REMOVABLE EXTERNAL PROTECTIVE COVERINGS SPECIALLY ADAPTED FOR VEHICLES
- B60J3/00—Antiglare equipment associated with windows or windscreens; Sun visors for vehicles
- B60J3/02—Antiglare equipment associated with windows or windscreens; Sun visors for vehicles adjustable in position
- B60J3/0204—Sun visors
- B60J3/0213—Sun visors characterised by the mounting means
- B60J3/0265—Attachments of sun visors to mounting means including details of sun visor bearing member regulating the rotational friction on the support arm
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60J—WINDOWS, WINDSCREENS, NON-FIXED ROOFS, DOORS, OR SIMILAR DEVICES FOR VEHICLES; REMOVABLE EXTERNAL PROTECTIVE COVERINGS SPECIALLY ADAPTED FOR VEHICLES
- B60J3/00—Antiglare equipment associated with windows or windscreens; Sun visors for vehicles
- B60J3/02—Antiglare equipment associated with windows or windscreens; Sun visors for vehicles adjustable in position
- B60J3/0204—Sun visors
- B60J3/0213—Sun visors characterised by the mounting means
- B60J3/0234—Mounted slidably
- B60J3/0239—Mounted slidably and pivoting on a support arm
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/81—Tube, bottle, or dipstick
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/823—Immunogenic carrier or carrier per se
Definitions
- the present invention relates to a biosensor for point-of-care testing (POCT) whose analytical performances were remarkably improved by introducing, into membrane strip chromatographic assay system, a successive cross-flow procedure for immune reaction and other reactions for signal generation.
- POCT point-of-care testing
- the membrane strip immuno-chromatography method based on the above principle provides a quick analysis of analyte and convenience of one-step detection where the analysis can be completed upon sample application alone.
- laboratory-version enzyme-linked immunosorbent assay essentially requires washing procedure for separating immune complexes from unreacted substance in the respective process of immunoassay, and further should carry out, separately, enzymatic reaction for signal generation. Consequently, such complex, multi-step procedure is clearly difficult to use for point-of-care testing.
- the present invention makes it the object to provide a membrane strip biosensor technique which not only enables quick and simple assay required in point-of- care testing but also satisfies clinical needs for highly sensitive determination of analytes in specimen by applying to point-of-care testing the principle of laboratory- version enzyme-linked immunosorbent assay which provides advantage, being relatively cheap and high sensitivity.
- the present invention relates to a membrane strip biosensor system that comprises (a) a membrane pad (10) for sample application,
- the above membrane pads in the vertical arrangement are general ones used for the conventional immuno-chromatography method, and the additional membrane pads in the horizontal arrangement are only different.
- Such arranged membrane pads enable us to do a successive conduction of a reaction using the vertical flow, such as immune reaction, and the other reaction using the horizontal flow, such as enzymatic reaction, on the membrane strip biosensor system.
- the horizontally arranged pads, (50) and (60) are either fixed from the first onto the signal generation membrane pad (30) combined with the vertically arranged pads or remained in a separated state at first and then fixed to the signal generation pad after the completion of the vertical flow reaction (e.g., immune reaction), which are utilized for performing the horizontal flow reaction (e.g., enzyme reaction).
- the vertical flow reaction e.g., immune reaction
- connection of the two group pads can be carried out by fixing the vertical arrangement pads, (10), (20), (30) and (40), on a single plate and fixing the horizontal arrangement pads, (50) and (60) on the other plate, and then transferring any one plate over the other to be a cruciform.
- the membrane strip biosensor system according to the present invention can be prepared in such a form that the vertical arrangement pads, (10), (20), (30) and (40), are fixed inside the bottom part (72) of the holder (e.g., a plastic holder) of the system which has a signal detection window (78) and a substrate solution container-perforating needle (75), and the horizontal arrangement pads (50) and (60) are fixed on a horizontal arrangement pad-fixing frame (74) existing inside the top part (71) of the holder with a sample application hole, wherein the frame (74) is connected with a flow transfer button (73) present outside the top part (71), and a substrate solution container (76) containing the substrate solution that will be eventually added onto the substrate solution supplying membrane pad (50) (Fig. 7).
- the vertical arrangement pads, (10), (20), (30) and (40) are fixed inside the bottom part (72) of the holder (e.g., a plastic holder) of the system which has a signal detection window (78) and a substrate solution container-perforating needle
- the operation principle of said membrane strip biosensor system is as follows: When the horizontal arrangement pads are connected to the vertical arrangement pads in a cross-position via automatic or manual handling of the flow transfer button (73) after the completion of the vertical flow reaction, the substrate solution container (76) is broken by the substrate solution container-perforating needle (75) installed within the bottom part (72) of the holder, thereby the horizontal flow reaction is automatically conducted. More specifically, the operation procedure of said membrane strip biosensor system is as follows:
- the horizontal arrangement pad-fixing part (74) descends vertically, thereby the horizontal arrangement pads, (50) and (60), are respectively fixed at the left and right lateral side of the signal generation membrane pad (30) among the vertical arrangement pads, and at the same time, the substrate solution container-perforating needle (75) makes a hole on the bottom of the substrate solution container (76), automatically supplying an enzyme substrate to the pad (50) (Fig. 7D).
- the substrate then forms a horizontal flow and plays functions of washing unreacted components and enabling to generate a color signal from the enzyme included in the immune complexes formed with the capture antibody.
- the signal generated by the enzymatic reaction can be observed by the naked eyes through the signal detection window (78) and quantitatively determined using detection device based on colorimetry or other means for detection, such as luminometry and electrochemistry.
- the membrane strip biosensor system in the present invention can be constructed in such mode that for electrochemical determination, additionally, an electrode can be either directly established on the signal generation membrane pad (30) or separately fabricated and combined with the pad at the time of signal detection.
- the substrate solution is prepared in a container fixed at a predetermined site on the top part of the holder of the system for facilitating its automatic supply of the substrate solution to the membrane pad (50) at the time of enzyme reaction.
- the substrate solution can also be prepared in a separate container from the analytical system for its manual supply.
- a glass fiber membrane can be used as the membrane pad (10) for sample application, the membrane pad (20) for conjugate release (The “conjugate” is used as the same meaning with the "labeled- binding component” in the present invention) and the membrane pad (50) for substrate solution supply;
- a nitrocellulose membrane can be used as the signal generation membrane pad (30); and
- a cellulose membrane can be used as the absorbent membrane pads, (40) and (60).
- the membrane pad (20) for conjugate release comprises at least, a binding component for detection and a label (this stands for “signal generator” or “tracer”, e.g., enzyme, fluorecein and, radio isotope) for signal generation.
- the label-linked binding component for detection which is contained the membrane pad (20) in a dry state, comprises either i) the conjugate of a label with a binding component for detection, or ii) a binding component for detection and the conjugate of a label with a secondary binding component specific to the binding component for detection.
- the binding component for detection is a substance, reacting specifically with an analyte, such as antibody, enzyme, receptor, DNA.
- the binding component for capture is a substance specifically reacting with an analyte, and antibody, enzyme, receptor or DNA etc. can be enumerated as the component. Therefore, the analytical principle of the present invention and the biosensor system based thereon can be utilized for the construction of immunosensor, enzyme sensor, and DNA sensor employing enzymatic signal generation.
- Said substrate solution comprises chromogenic component, light-generating component, electrochemical signal-generating component, or silver compound; and conducts an action of the generation of color, color change, light emission, conductivity change, current change, or voltage change as signal.
- the signal generator horseradish peroxidase, alkaline phosphatase, ⁇ -galactosidase, or arthromyces ramosus peroxidase can be used, and the substrate solution comprises a chromogenic substrate component specific to the respective enzyme, and the enzyme-substrate reaction generates a signal detectable by naked eyes, i.e., color or color change.
- a chemical reaction can be employed and as a typical example, a signal as mentioned above can be generated by catalytic reaction between gold and silver by using gold colloid as tracer and silver compound such as silver acetate as the substrate solution.
- the substrate solution comprises a light-generating substrate component specific to the respective enzyme, e.g., luminol, and at the time of signal generation, a light signal detectable with naked eyes is generated by the enzyme-substrate reaction.
- metal ions i.e. Co , Cu , Mg , Fe , or their compounds can be used.
- glucose oxidase, urease, penicillin oxidase, or cholesterol oxidase can be used as the signal generator, and the substrate solution comprises an electrochemical signal-generating substrate component specific to the enzyme, and the enzyme-substrate reaction generates conductivity change, current change, or voltage change as signal.
- the membrane strip biosensor system of the present invention can be explained in more detail regarding immunoassay as follows.
- the membrane strip biosensor system based on the successive cross- flow of medium is composed of functional membrane pads which are respectively arranged in horizontal direction on the left and four different membrane strips which are connected in vertical direction with one another on the right, hi the vertical arrangement, at the bottom, a glass fiber membrane pad (10) for sample application is positioned and, at the upper location, a glass fiber membrane pad (20) containing detection antibody (22)-enzyme (21) conjugate in a dry state is arranged.
- the conjugate exhibits immobility while existing in a dry state, yet upon contact with an aqueous medium, it is instantly dissolved and participates in antigen-antibody reaction in the liquid phase.
- a nitrocellulose membrane pad (30) where the capture antibody (31) and a secondary antibody (32) specific to the detection antibody are respectively immobilized on predetermined sites, is located and here, eventually a signal in proportion to the concentration of an analyte and a constant signal as control irrelevant to the analyte concentration are independently generated at the respective site.
- a cellulose membrane pad (40) as absorbent is positioned to maintain the lateral flow by the capillary action through micropores in the membrane pads listed above.
- Each membrane pad are partially superimposed each other, arranged on a plastic film, and fixed by a double-sided tape to prepare a functional immuno-strip.
- a glass fiber membrane pad (50) for supplying substrate for enzyme as tracer or an aqueous medium for signal amplification that will be eventually located at the left side of the nitrocellulose membrane pad (30) and a cellulose membrane pad (60) for absorption of substrate solution that will be located at the right side thereof in order to maintain the flow of substrate solution by the capillary action are prepared.
- Such horizontal arrangement pads initially, are not in contact with the immuno-strip main body thereby immune reaction is first performed in the vertical direction alone through the immuno- strip, and the subsequent connection of the left and right pads allows the enzymatic reaction to be conducted in horizontal direction alone.
- Fig. 2 Analytical procedure that consists of four steps using the membrane strip biosensor system constructed as described above is shown in Fig. 2.
- analyte-containing specimen e.g., serum, plasma, whole blood
- the specimen is absorbed inside the system through the sample application pad and the medium is transferred along the strip by the capillary action in the vertical direction (Fig. 2A).
- the medium reaches the glass membrane pad with the accumulated antibody conjugate in a dry state, the conjugate is instantly dissolved and a primary immune complex is formed by the antigen (i.e., analyte)-antibody reaction in the liquid state.
- the immuno-strip is connected with the horizontal arrangement pads (Fig. 2, B). This can be performed by transferring the vertical arrangement pads or the horizontal arrangement pads using a pad-fixing frame.
- an enzyme substrate solution is added automatically or manually to the substrate solution supply pad, and the horizontal flow is initiated, which allows the solution to be absorbed into the substrate solution absorption pad through the signal generation pad (Fig. 2, C).
- the substrate is supplied to the enzyme, tracer, included in the sandwich immune complex formed with the capture antibody immobilized on the nitrocellulose membrane, thus a signal in proportion to the analyte concentration and the control signal are independently generated by the catalytic reaction (Fig. 2, D).
- the signal is quantified using an adequate detector (e.g., color detector, light detector, or electrochemical detector) according to the type of the signal generator selected to determine the analyte concentration.
- the main objective of 'the membrane strip biosensor system based on a vertical-horizontal cross-flow' devised in the present invention is to combine the signal generation technology using catalyst such as enzyme as tracer with the immuno- chromatographic analytical method such that point-of-care testing with a high sensitivity can be carried out.
- FIG. 3 Various flow paths for supplying the enzyme substrate solution are shown in Fig. 3. Besides the horizontal flow (Fig. 3, A) through the signal generation pad on the immuno-strip, a horizontal, diagonal flow (Fig. 3, B) by adequate arrangements of the substrate solution supply pad and absorbent pad can also be induced. In addition, after conducting the immune reaction and then removing the components of immuno-strip except the signal generation pad, the substrate solution supplying pad and adsorption pad are arranged in length, thereby the substrate solution can be supplied in various vertical flow (Fig. 3, C, D and E). Among such different flow paths, considering simultaneous multiple signal generation and effectiveness in designing the novel analytical system, the supply of the enzyme substrate solution through horizontal flow is preferred.
- the membrane strip biosensor system for point-of-care testing developed in the present invention in comparison to other conventional systems, are as follows.
- First when comparing the enzyme tracer with other colorimetric signal generator such as gold colloid and latex particles, the enzyme generates a signal by the catalytic reaction, and thus provides an amplification effect. Therefore, the detection of analyte employing the novel biosensor is highly sensitive as in case of biosensor using fluorescent substance as signal generator.
- the membrane strip biosensor system as explained above can be employed for the construction of a color signal detection-type photometric biosensor as an application of the same analytical concept.
- Such biosensor independently achieves the enzymatic reaction for signal generation on the membrane strip as in the conventional enzyme- linked immunosorbent assay (ELISA) using microwells as solid matrix for protein immobilization, thereby providing advantages that can be achieved from the both assay systems, i.e., high sensitivity as in ELISA and quick response as in ordinary irnmuno- chromatographic assay.
- the intensity of color signal sensitively generated on the membrane in proportion to the analyte concentration within sample can be determined based on reflectance photometry. Therefore, when comparing with a fluorescence detection-type system used conventionally for quantitation, the color detection-type sensor maintaining comparable analytical performances is relatively cheap and uses small-sized signal detector, thus can be applied to point-of-care testing.
- Fig. 4 The analytical principle of the color detection-type biosensor is described in detail in Fig. 4.
- analyte-containing sample e.g., blood
- the analyte reacts with the detection antibody-enzyme conjugate
- the primary immune complex formed is captured by the capture antibody immobilized on the signal pad
- the unreacted components are then separated by the medium flow (Fig. 4, A).
- Amount of the captured detection antibody-enzyme conjugate is proportional to the analyte concentration, and thus, eventually a signal proportional to it is generated.
- Excess conjugate separated by the vertical flow is captured by the secondary antibody immobilized in the upper region of the same strip.
- the signal at this site can be kept constant regardless of the analyte concentration, and it can be utilized as the control signal.
- the enzyme substrate is supplied through the horizontal flow as described above, and then all other components except the immune complexes captured by the immobilized antibodies are eliminated and, at the same time, signals are generated by the enzyme included within the captured immune complexes (Fig.- 4, B).
- the intensity of color signal generated on the membrane strip is determined by applying a light with a constant wavelength and measuring the reflected light which deceases in proportion to the color intensity, using a photometric detector (e.g., photodiode, charge-coupled device etc.) (Fig. 4, C).
- HRP horseradish peroxidase
- alkaline phosphatase alkaline phosphatase
- ⁇ -galactosidase ⁇ -galactosidase
- ARP artliromyces ramosus peroxidase
- HRP tetramethylbenzidene
- DAB diaminobenzidene
- 4C1N 4-chloro-l -naphthol
- Respective substrate require different optimal reaction conditions, thus an adequate substrate can be selected by considering its analytical characteristics and the requirements of the biosensor.
- labeling methods of enzyme besides the method of directly conjugating an enzyme with the detection antibody as mentioned above, an indirect method of using a secondary antibody specific to the detection antibody could be enumerated.
- the detection antibody and a secondary antibody-enzyme conjugate are accumulated respectively, in a spatial separation, on the conjugate pad of immuno-strip to construct an assay system.
- the enzyme conjugate specifically reacts with the primary immune complex between the detection antibody and analyte that was then captured by the capture antibody immobilized on a definite site of the signal generation pad.
- the detection antibody can also be used via conjugation with gold colloid, and thus the detection antibody-gold conjugate and the secondary antibody-enzyme conjugate can be accumulated in separate locations on the conjugate pad of the immuno-strip.
- a red color signal is generated, after assay, from gold colloids in proportion to the concentration of the primary immune complex between analyte and the gold conjugate which is subsequently captured by binding to the immobilized antibody during the vertical flow, thus assay progress can be followed by naked eyes.
- the secondary antibody-enzyme conjugate can be bound in proportion to the number of the detection antibody molecules, thus providing signal amplification effect.
- the binding reaction between streptavidin and biotin can be employed and, typically, streptavidin is conjugated with the detection antibody and biotin is coupled to enzyme. Because the reaction between streptavidin and biotin exhibits the highest affinity among known biological reactions so far, it provides an advantage, i.e., signal amplification effect, comparing to the method of using the secondary antibody.
- a signal generation method mentioned above can be selected depending on the requirements for the assay system such as the lower detection limit of analyte, dynamic range, analysis time and, expense.
- a chemical reaction such as catalytic reaction between gold and silver can be employed as an alternative to the enzymatic reaction, and as typical reactants, gold colloid and silver acetate can be listed (Reference: Patel N et al., 1992, Ann. Clin. Biochem. Vol. 29, Page 282-286, Rocks. BF et al, 1991, Ann. Clin. Biochem. Vol. 28, Page 155-159).
- an immuno-strip is prepared by using the detection antibody-gold colloid conjugate as signal generator and a color signal is generated from the gold in proportion to the analyte concentration through the primary vertical flow.
- the membrane strip biosensor system developed in the present invention can be used for the construction of light detection-type photometric biosensor.
- a biosensor employs tracer which itself generates a light signal.
- tracer which itself generates a light signal.
- this format of biosensor does not require a light source, which makes detector simpler and cheaper.
- the detection principle and variability of the assay system are identical to those of the color detection-type biosensor explained above, yet selection of suitable signal generators are necessary so that light signals in proportion to the analyte concentration may be generated. As specifically shown in Fig.
- arthromyces ramosus peroxidase an enzyme
- ARP arthromyces ramosus peroxidase
- this enzyme can be used as signal generator, and this enzyme generates by reaction with luminol a light signal that can be measured at the maximum absorbance of 427nm (Reference: Kim, Pisarev, and Egorov, 1991, Anal. Biochem. Vol. 199, Page 1- 6).
- the intensity of the light signal is about 500-fold in the sensitivity compared to that from HRP which is ordinarily used for color generation.
- metal ions Co , Cu , Mg , Fe , etc.
- these are cheap and further generate more sensitive light signal than does enzyme (Reference: D. Junsaek, U.
- the light signal generation method using enzyme or metal ion as tracer can be applied to the cross-flow system of the present invention.
- the horizontal flow is sequentially progressed for supplying the substrate solution (Fig. 5, A).
- the unbound components except the immune complexes bound to the antibody immobilized on the membrane is washed and, at the same time, a light signal is generated from the tracer included in the captured immune complexes.
- ARP used as tracer
- a substrate solution, containing luminol and hydrogen peroxide, adjusted to an optimal acidity is employed.
- a detection means such as photodiode is carried near the signal generation pad to measure the generated signal (Fig. 5, B) under the dark condition for minimization of noise. After detection of the signal by a photometric detector and conversion to an electric signal, the analyte concentration in a specimen is determined based on the standard curve showing the signal change against the analyte concentration.
- labeling methods of tracer on the antibody molecule and arrangement of the analytical components are identical to those explained above in detail for the construction of the color detection- type biosensor.
- the concept of the membrane strip biosensor system developed in the present invention can also be used for the fabrication of electrochemical biosensors as another application.
- Such biosensor uses as signal generator an enzyme, which induces a change of ionic concentration, charge density, or electrochemical potential via enzymatic conversion of substrate, and produces an electrochemical change as signal (Reference: M. M Castillo-Ortega et al., 2002, Sensors and Actuators B. Vol 85, page 19-25; Andrea Pizzariello et al., 2001, Talanta, Vol 54, Page 763-772).
- Electrochemical detector for such signal is relatively simple to use, cheap, and small- sized, yet as extra requirement, an electrode for electrochemical measurement should be directly installed on the immuo-strip or separately prepared to combine with the immunostrip at the time of signal detection (Reference: J. H. Kim, S.H. Paek, 2000, Biosensors & Bioelectronics, Vol. 14, Page 907-915).
- the analytical principle of the assay system is identical to that of the photometric biosensors explained above and yet selection of a suitable signal generator is needed for the generation of an electrochemical signal in proportion to the analyte concentration.
- Enzymes usable as tracer can be varied according to the metliod of electrochemical detection. For example, to induce a conductivity change as the signal, urease can be used. This enzyme increases ionic concentration by decomposing urea as the substrate into ammonium ion and carbonium ion, thereby a conductivity change in proportion to the analyte concentration is produced as the signal (Fig. 6). As another example, to generate an electric current change as the signal, an enzyme that oxidizes or reduces its substrate, i.e., glucose oxidase and cholesterol oxidase, can be used as tracer and a change of electron density via the enzymatic reaction is measured as a current change using an electrode.
- urease can be used to induce a conductivity change as the signal. This enzyme increases ionic concentration by decomposing urea as the substrate into ammonium ion and carbonium ion, thereby a conductivity change in proportion to the analyte concentration is produced as the signal (Fig.
- a change of electrochemical potential can be generated as the signal and a typical application thereof is to use as tracer enzymes modulating the hydrogen ion concentration, i.e., acidity, (glucose oxidase, urease, penicillin oxidase) and to measure the results of the enzymatic reaction using a pH electrode (Reference: Andrea Pizzariello et al., 2001, Talanta, Vol. 54, page 763-772).
- a selective membrane for the ammonium ion or carbonium ion produced by the decomposition of urea in this enzymatic reaction is installed on an electrode surface, thereby the change of chemical potential can be detected as the electric signal.
- the analytical principle of the electrochemical biosensor is identical to that of the photometric biosensors as explained above, and as depicted in Fig. 6.
- the analyte-containing specimen is applied to the bottom end of the immuno-strip, the analyte forms the primary immune complex with the antibody-enzyme conjugate released from the conjugate pad and this, then forms the sandwich-type immune complex with the capture antibody immobilized on the signal generation pad.
- the vertical flow for antigen-antibody reaction is stopped and switched to the horizontal flow, other components except the captured immune complex are removed, and at the same time, an electrochemical signal is generated by the reaction between the enzyme present in the captured immune complex and its substrate (Fig. 6, A).
- a suitable electrode that was already placed on the membrane or separately prepared is employed (Fig. 6, B) such that the signal-to-noise is maximized (Fig. 6, C).
- Fig. 6, B a suitable electrode that was already placed on the membrane or separately prepared
- Fig. 6, C a suitable electrode that was already placed on the membrane or separately prepared
- physicochemical factors of the sensor should be optimized against the signal-to-noise ratio.
- the membrane strip biosensor system based on the cross-flow which was conceived in the present invention as described above leads to the construction of various biosensors according to the suitable selection of enzyme as tracer.
- assay systems using membrane strip offered no way to provide the components necessary for an enzymatic reaction to generate a signal from enzyme as tracer and, thus construction of an efficient biosensor was difficult.
- This problem can be resolved by using the cross-flow concept developed in the present invention. That is, the cross- flow method enables the construction of various biosensors according to the enzyme tracer as well as a convenient, automatic supply of the enzyme substrate solution.
- the enzyme-linked immunosorbent assay which could not be conventionally handled by ordinary persons due to a complex assay procedure and long assay time despite of its high sensitivity, can be conveniently performed on membrane strip. Additionally, it becomes possible according to the present invention to use various enzymes as signal generator, as an alternative to the previous fluorescence tracer requiring an expensive detector, thereby a cheap and small-sized detector can be employed.
- Fig. 1 shows components and arrangement of the membrane strip biosensor system conceived in the present invention.
- Fig. 2 shows a cross-flow chromatographic assay procedure of the membrane strip biosensor system, key points of the present invention, and its analytical principle based thereon.
- A depicts the absorption of sample and antigen-antibody reactions induced by the vertical flow of medium;
- B depicts the connection of the irnmuno strip with the horizontal arrangement pad;
- C depicts the supply of substrate solution for an enzyme used as label in the immunoassay; and D depicts the signal generated from the enzyme.
- Fig. 3 shows various flow paths for supplying enzyme substrate solution, which are available in the analysis based on a dual-flow chromatographic method.
- Fig. 4 shows the analytical principle of a color detection-type photometric biosensor according to the present invention that is based on the enzyme-linked immunosorbent assay method combined with the cross-flow chromatography.
- A describes the sample application and immune complexes formation by the vertical flow of medium
- B enzymatic reaction for signal generation by the horizontal flow of the substrate solution
- C a color signal detection based on reflectance photometry.
- Fig. 5 shows the analytical principle of a light detection-type photometric biosensor in the present invention, which is based on the identical concept described in Fig. 4 except signal generation.
- A describes enzymatic reaction for signal generation by the horizontal flow and B a luminometric signal detection.
- Fig. 6 shows the analytical principle of an electrochemical biosensor in the present invention, which utilizes the same principle as described in Fig. 4 except signal generation.
- A describes enzymatic reaction for signal generation, B electrode attachment procedure, C a electrochemical signal (e.g., conductivity change) detection.
- Fig. 7 shows a holder of the analytical components for the cross-flow membrane strip chromatographic assay, which is designed to perform the sequential processes, i.e., the immune reaction and enzymatic reaction, in an automatic or manual mode.
- a and B depict the overall constitution of the holder
- C and D depict cross-section of the holder with the top and bottom plates of the holder being combined.
- C depicts the relative position of the horizontal and vertical arrangement pads during the progress of vertical flow for immune reactions
- D depicts the relative position of the two arrangement pads during the progress of horizontal flow for enzymatic reaction.
- Fig. 8 shows responses of the color detection-type photometric biosensor
- Example 6 against the concentration of analyte (Hepatitis B virus surface antigen, HBsAg).
- A reveals the experimental results using gold colloids as label, B those using an enzyme, HRP, as label, and C the dose-response curves expressed the color signals in optical density.
- Fig. 9 shows a comparison of gold color signal and ARP light signal against the standard concentrations of analyte, cardiac Troponin I.
- the light signals were determined using a light detection-type membrane strip biosensor prepared in Example
- Fig. 10 shows conductivity signal change against the standard concentration of human serum albumin, which was determined using a conductimetric membrane strip biosensor prepared in Example 9 to demonstrate an application of the concept into an electrochemical biosensor.
- Fig. 11 shows a comparison of dose responses to HbsAg measured by a direct enzyme-labeling method and indirect method.
- a and B are the results of color signal produced from the membrane strip biosensor system based on the cross-flow concept according to the direct and indirect methods, respectively, and C shows the results of color signal produced from enzyme-linked immunosorbent assays (ELISA) and measured at the absorbance of 450 nm.
- ELISA enzyme-linked immunosorbent assays
- detection antibody 30 membrane pad for signal generation
- membrane pad for absorption of vertical flow medium 50 membrane pad for the supply of substrate solution 60 : membrane pad for absorption of horizontal flow medium 71 : top part of the holder 72 : bottom part of the holder
- substrate solution container-perforating needle 76 substrate solution container
- HBsAg Hepatitis B surface antigen
- polyclonal antibody produced from rabbit
- monoclonal antibody produced from mouse
- polyclonal antibody produced from goat
- human serum albumin purchased from Enzyme International (USA).
- Cardiac troponin I (cTn I) and antibodies specific to it, i.e., polyclonal antibody (produced from goat) and monoclonal antibody (produced from mouse) were purchased from Spectral (USA).
- Gold colloid (diameter 40 nm, 0.01%), sephadex gels, casein (sodium salt type, extracted from milk), bovine serum albumin (BSA, purification by heat shock process, fraction V), Tween 20, Triton X-100, human serum albumin (HSA) were supplied by Sigma (USA).
- Nitrocellulose membrane pore size 12 ⁇ m
- glass fiber membrane and cellulose membrane (3MM chromatography grade) were purchased from Millipore (USA) and Whatman (USA), respectively.
- casein-PB was added to adjust the final volume of the conjugate to 0.2 ml and stored at 4°C until used.
- Conjugation between an antibody specific to analyte and enzyme was performed by a chemical reaction using a cross-linker. After the antibody was reacted with SMCC in a 20-fold excess mole concentration for 4 h at 4°C, the excess SMCC was removed by Sephadex G-15 gel chromatography and the antibody was then directly conjugated with an enzyme activated as described below. For the activation of enzyme, the protein was dissolved in 5 mM EDTA-containing PB and reacted with SPDP in a 20-fold excess mole concentration for 1 h at room temperature. To introduce sulfhydryl group on the molecule, DTT (final 10 mM) was added to the reaction mixture and again reacted for 2 h at 37°C.
- NC membrane As signal generation pad, an optimal product of a nitrocellulose (NC) membrane toward immobilization efficiency and pore size was used, the NC membrane (pore size: 12 ⁇ m, Millipore) was used for the immobilization of antibody.
- immobilization method physical adsorption and chemical method can be used and an adequate method was eventually selected based on the results of experiments by considering convenience of the method and reproducibility.
- Antibody was immobilized on a predetermined site of NC membrane strip (7 x 25 mm) by physical adsorption.
- Example 3 As signal generation pad, the same NC membrane was used as explained in Example 3 for the immobilization of streptavidin (SA) in place of antibody.
- SA streptavidin
- a chemical method was employed. The NC membrane (7 x 25 mm) was immersed in 0.5% glutaraldehyde solution and reacted for 1 h and then washed three times with PBS. 10 mg/ml of SA (1 ⁇ L) was applied at a site of 1 cm from the bottom end by use of micro-dispenser, incubated in a box maintaining 100% humidity and reacted for 1 h at room temperature. The remaining steps were identical to those for the immobilization of antibody show in Example 3.
- Example 5 Construction of color detection-type analytical system 5-1. Construction of immuno-strip An immuno-chromatographic assay system, where a signal depending on the concentration of analyte (HBsAg) is determined by naked eye identification or optical density measurement, was constructed using detection antibody-gold colloid conjugate used in Example 6-1 or the gold conjugate in the combination with secondary antibody- HRP conjugate (used in Example 6-2) as signal generator. The immuno-strip (Fig.
- the horizontal arrangement pad were constructed using a glass fiber membrane (10 x 20 mm) for supplying the enzyme substrate containing hydrogen peroxide and TMB, and a cellulose membrane (15 x 20 mm) as absorption pad for inducing the cross-flow.
- the pads were spatially seperated from the immuo-strip explained above and the analytical system was designed in such a way that the horizontal pads, thereafter, were allowed to be in contact with the both lateral sides of the NC membrane, respectively, to induce the enzyme reaction (Fig. 2).
- Example 6 Dose responses of color detection-type photometric biosensor 6-1. Use of gold colloids as tracer
- Gold color signal as dose response of the analytical system prepared in Example 5 to HBsAg standard was determined by scanning reflectance photometry. Each standard solution of HBsAg (150 ⁇ l) was placed into different microwells, the immuno-strips were placed into each microwell in an erect position to adsorb the aqueous solutions into the strips for 15 min. The signal appeared at the area of the immobilized antibody was scanned by a scanner (HP ScanJet 6100C, Hewlett-Packard, Palo Alto, CA, USA). The colored area on the captured image (Fig.
- A) was selected by using image analysis program (Multianalyst version 1.1, Bio-Rad Laboratories, Hercules, CA, USA) such that all of the colored area can be covered, and then converted to optical density that was in proportion to color intensity (Fig. 8, C Gold signal).
- the optical density measured as well as the color intensity recognized by naked eyes were proportional to the analyte concentration.
- detection sensitivity was about 100 ng/ml.
- HRP signal as dose response to HBsAg from an assay system constructed as described in Example 5-1 was determined using the same method as for gold color signal measurement.
- the analytical procedure was basically identical to those for producing gold signal except the additional use of secondary antibody-HRP conjugate as mentioned.
- HRP signal generation the substrate supplying pad and absorbent pad in the horizontal arrangement were positioned to the right and left side of the signal pad, respectively, and the substrate solution for HRP was supplied to allow the progress of horizontal flow for 3 min. Remaining components except the immune complexes captured by the capture antibody on the NC membrane were removed and at the same time a blue color signal was generated from HRP included in the captured immune complexes (Fig. 8, B).
- the color signal was quantified to optical density using the same procedure as for the gold signal (Fig. 8, C HRP signal).
- the optical density as signal was in proportion to the color intensity recognized by naked eyes and also proportional to the analyte concentration.
- the detection sensitivity was about 1 ng/ml and this was about 100-fold superior over that of the gold color signal (Fig. 8, C).
- the immuno-strip (Fig. 1) includes, from the bottom end, a glass fiber membrane (7 x 20 mm) treated with 0.1 % (v/v) Triton X-100, a glass fiber membrane (7 x 5 mm) with the conjugates, a NC membrane (7 x 25mm) with immobilized SA, and a cellulose membrane (7 15 mm) as absorbent pad.
- a glass fiber membrane (7 x 20 mm) treated with 0.1 % (v/v) Triton X-100
- a glass fiber membrane (7 x 5 mm) with the conjugates a NC membrane (7 x 25mm) with immobilized SA
- a cellulose membrane (7 15 mm) as absorbent pad.
- Each contiguous membrane strip were partially superimposed and fixed on a plastic film by a double-sided tape.
- the horizontal arrangement pads were constructed using a glass fiber membrane (10 x 20 mm) for supplying the enzyme substrate solution containing luminol and hydrogen peroxide, and a cellulose membrane (15 x 20 mm) as absorption pad.
- the role of the horizontal arrangement pads is already mentioned in Example 5-2 and also shown in Fig. 2.
- Gold color signal as dose response of the analytical system prepared in Example 7-1 to cTn I standard was determined by scanning reflectance photometry. Each standard solution of cTn I (150 ⁇ l) was placed into different microwells, the immuno-strips were placed into each microwell in an erect position. The next analytical procedure was the same as that for HBsAg in Example 6-1, and the color signal produced was converted to optical density as also demonstrated (Fig. 9, Gold color signal).
- the optical density was in proportion to the color intensity recognized by naked eyes and also proportional to the analyte concentration.
- the detection sensitivity was about 1 ng/ml.
- ARP light signal as dose response to cTn I was measured from an assay system constructed identically with the gold color detection-type immuno-strip as described in Example 8-1 except the use of detection antibody- ARP instead of detection antibody-gold colloid conjugate and also the use of cross-flow as the key idea for the generation of signal from enzyme in the present invention.
- the procedure for immune reactions in the vertical flow mode was identical with that of Example 8-1 using gold colloids as tracer.
- the substrate supply pad and absorbent pad in the horizontal arrangement were positioned to the right and left side of the signal pad, respectively, an the substrate solution for ARP, 0.2 M carbonate buffer, pH 9.0, containing hydrogen peroxide and luminol was supplied to allow the progress of the horizontal flow for 3 min.
- the remaining components except the immune complexes captured on the membrane was removed and at the same time a blue light signal was generated from ARP included in the captured immune complexes.
- the light signal was quantified using photodiode (Hamamatsu, Japan) and analog- digital conversion device (ADCM board, manufactured in Korea) installed within a personal computer.
- Example 9 Construction of electrochemical detection-type analytical system An immuno-chromatographic assay system producing electrochemical signal against the analyte concentration, was constructed according to basically identical procedure to those shown in Examples 5 and 7. The electrochemical detection system however, additionally required electrode as shown in Fig. 6 and, to demonstrate on an electrochemical measurement, a conductivity detection system is explained below.
- HAS human serum albumin
- An immuno-chromatographic assay system was constructed using detection antibody-urease conjugates and a NC membrane strip with the immobilized capture antibody.
- the immuno-strip system (Fig. 1) was constructed in the same manner as that descried in Example 5-1.
- the horizontal arrangement pads were constructed using a glass fiber membrane (10 x 20 mm) for supplying the enzyme substrate solution containing urea and a cellulose membrane (15 x 20 mm) as absorption pad.
- Dose response to HSA from the assay system prepared in Example 9 was obtained using an electrochemical detection device (e.g., conductivity meter). The same analytical procedure was employed as described in Example 6-2. After applying the horizontal flow for 3 min, the remaining components except the immuno-complexes captured on the membrane were removed, and, at the same time, urease included in the immune complexes decomposed urea to produce ammonium ion and carbonium ion. Thus, a conductivity change in proportion to the analyte concentration appeared as signal (Fig. 10). The conductivity signal expressed in current generated at the area with the immobilized capture antibody was then measured by a digital multimeter (HITASI, Japan).
- HITASI digital multimeter
- ELISA enzyme-linked immunosorbent assay
- the direct labeling method was applied by directly attaching HRP to the detection antibody, monoclonal antibody produced from mouse specific to HBsAg (analyte), and the indirect labeling method was tested by attaching HRP to a secondary antibody, a polyclonal antibody produced from goat which recognized the detection antibody specific to analyte.
- the direct method may require that the enzyme label should be attached to each detection antibody for different analytes.
- the indirect method is advantageous for convenience and signal amplification, that is, the enzyme conjugate can be used even for different analytes, and signal amplification can be achieved owing to the use of the additional antibody.
- the two methods were used to compare their analytical performances.
- the present invention provides a membrane strip biosensor technology that not only enables a quick and simple assay required for point-of-care testing but also satisfies a clinical need for highly sensitive detection of analyte within specimen. These were achieved by applying the principle of laboratory-version enzyme-linked immunosorbent assay to a device for point-of-case testing, providing advantages of cheap and sensitive quantitation of analyte.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Mechanical Engineering (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE602004015585T DE602004015585D1 (en) | 2003-04-25 | 2004-04-21 | MEMBRANE STRIP BIOSENSOR SYSTEM FOR POINT OF CARE TESTS |
EP04728716A EP1618383B1 (en) | 2003-04-25 | 2004-04-21 | Membrane strip biosensor system for point-of-care testing |
JP2006507812A JP4546462B2 (en) | 2003-04-25 | 2004-04-21 | Membrane strip biosensor system for point-of-care testing |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20030026227 | 2003-04-25 | ||
KR10-2003-0026227 | 2003-04-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004097419A1 true WO2004097419A1 (en) | 2004-11-11 |
Family
ID=36770658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2004/000914 WO2004097419A1 (en) | 2003-04-25 | 2004-04-21 | Membrane strip biosensor system for point-of-care testing |
Country Status (8)
Country | Link |
---|---|
US (1) | US7300802B2 (en) |
EP (1) | EP1618383B1 (en) |
JP (1) | JP4546462B2 (en) |
KR (1) | KR100599420B1 (en) |
CN (1) | CN1781022A (en) |
AT (1) | ATE403869T1 (en) |
DE (1) | DE602004015585D1 (en) |
WO (1) | WO2004097419A1 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007024549A (en) * | 2005-07-12 | 2007-02-01 | Asahi Kasei Corp | Biochemical analyzer |
CN101183108A (en) * | 2007-10-16 | 2008-05-21 | 李红玉 | Colloidal gold test paper for detecting trace quantity oxygenize low density lipoprotein by indirect competition method |
EP2460009A1 (en) * | 2009-07-31 | 2012-06-06 | Invisible Sentinel, Inc. | Device for detection of antigens and uses thereof |
US9116148B2 (en) | 2004-01-26 | 2015-08-25 | President And Fellows Of Harvard College | Fluid delivery system and method |
US9255866B2 (en) | 2013-03-13 | 2016-02-09 | Opko Diagnostics, Llc | Mixing of fluids in fluidic systems |
WO2016062788A1 (en) | 2014-10-24 | 2016-04-28 | Ait Austrian Institute Of Technology Gmbh | Microfluidic chip for biological analysis |
US9347938B2 (en) | 2012-03-09 | 2016-05-24 | Invisible Sentinel, Inc. | Methods for detecting multiple analytes with a single signal |
US9475049B2 (en) | 2009-07-31 | 2016-10-25 | Invisible Sentinel, Inc. | Analyte detection devices, multiplex and tabletop devices for detection of analyte, and uses thereof |
US9557330B2 (en) | 2009-10-09 | 2017-01-31 | Invisible Sentinel, Inc. | Device for detection of analytes and uses thereof |
US10082507B2 (en) | 2003-12-31 | 2018-09-25 | President And Fellows Of Harvard College | Assay device and method |
US10279345B2 (en) | 2014-12-12 | 2019-05-07 | Opko Diagnostics, Llc | Fluidic systems comprising an incubation channel, including fluidic systems formed by molding |
GB2571763A (en) * | 2018-03-08 | 2019-09-11 | Sumitomo Chemical Co | Enzyme-amplified lateral flow device |
US10712340B2 (en) | 2012-01-20 | 2020-07-14 | Ortho-Clinical Diagnostics, Inc. | Assay device having controllable sample size |
Families Citing this family (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7749174B2 (en) | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7041068B2 (en) | 2001-06-12 | 2006-05-09 | Pelikan Technologies, Inc. | Sampling module device and method |
DE60234598D1 (en) | 2001-06-12 | 2010-01-14 | Pelikan Technologies Inc | SELF-OPTIMIZING LANZET DEVICE WITH ADAPTANT FOR TEMPORAL FLUCTUATIONS OF SKIN PROPERTIES |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
DE60238119D1 (en) | 2001-06-12 | 2010-12-09 | Pelikan Technologies Inc | ELECTRIC ACTUATOR ELEMENT FOR A LANZETTE |
ES2357887T3 (en) | 2001-06-12 | 2011-05-03 | Pelikan Technologies Inc. | APPARATUS FOR IMPROVING THE BLOOD OBTAINING SUCCESS RATE FROM A CAPILLARY PUNCTURE. |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7198606B2 (en) | 2002-04-19 | 2007-04-03 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with analyte sensing |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
EP1628567B1 (en) | 2003-05-30 | 2010-08-04 | Pelikan Technologies Inc. | Method and apparatus for fluid injection |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | Method and apparatus for an improved sample capture device |
EP1680014A4 (en) | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | Method and apparatus for a variable user interface |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
EP1751546A2 (en) | 2004-05-20 | 2007-02-14 | Albatros Technologies GmbH & Co. KG | Printable hydrogel for biosensors |
WO2005120365A1 (en) | 2004-06-03 | 2005-12-22 | Pelikan Technologies, Inc. | Method and apparatus for a fluid sampling device |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US7763454B2 (en) * | 2004-07-09 | 2010-07-27 | Church & Dwight Co., Inc. | Electronic analyte assaying device |
KR100635110B1 (en) * | 2004-12-09 | 2006-10-17 | 주식회사 바이오디지트 | Lab-on-a-chip for an on-the-spot analysis and signal detector for the same |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
WO2006098804A2 (en) * | 2005-03-11 | 2006-09-21 | Chembio Diagnostic Systems, Inc. | Dual path immunoassay device |
KR100616426B1 (en) | 2005-05-06 | 2006-08-28 | 주식회사 인포피아 | Strip biosensor |
KR100704007B1 (en) * | 2006-01-17 | 2007-04-04 | 한국과학기술연구원 | Lateral flow immunoassay kit based on chemiluminescence and chemifluorescence reaction and using method thereof |
WO2008023579A1 (en) * | 2006-08-21 | 2008-02-28 | Panasonic Corporation | Measuring device, measuring instrument and method of measuring |
WO2008043041A1 (en) | 2006-10-04 | 2008-04-10 | University Of Washington | Method and device for rapid parallel microfluidic molecular affinity assays |
US20080160543A1 (en) * | 2006-12-27 | 2008-07-03 | Chein-Shyong Su | Electrochemical immunostrip and its preparation method |
JP4865664B2 (en) * | 2007-09-28 | 2012-02-01 | 富士フイルム株式会社 | Method of mixing two or more liquids in a porous carrier |
EP2265324B1 (en) | 2008-04-11 | 2015-01-28 | Sanofi-Aventis Deutschland GmbH | Integrated analyte measurement system |
JP5066498B2 (en) * | 2008-09-19 | 2012-11-07 | 富士フイルム株式会社 | Assay method |
JP5011244B2 (en) * | 2008-09-19 | 2012-08-29 | 富士フイルム株式会社 | Test substance detection method |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US8377643B2 (en) * | 2009-03-16 | 2013-02-19 | Abaxis, Inc. | Split flow device for analyses of specific-binding partners |
JP5430995B2 (en) * | 2009-03-30 | 2014-03-05 | 富士フイルム株式会社 | Assay method and assay device |
KR101111968B1 (en) * | 2009-04-20 | 2012-02-14 | (주)디지탈옵틱 | The assembed kit the biosensor using the cross-flow system |
KR101027036B1 (en) * | 2009-05-28 | 2011-04-11 | 주식회사 인포피아 | Method for amplification of signal in lateral flow assay by reduction of gold ion and lateral flow assay device using the method |
WO2011065751A2 (en) | 2009-11-24 | 2011-06-03 | 한국생명공학연구원 | Membrane biosensor to which a porous film is attached, and a method for measuring immune reactions or enzyme reactions employing the same |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US20120302456A1 (en) * | 2010-11-23 | 2012-11-29 | President And Fellows Of Harvard College | Vertical flow-through devices for multiplexed elisa driven by wicking |
CN102095860B (en) * | 2011-01-25 | 2013-12-18 | 厦门大学附属中山医院 | Syphilis specific IgG antibody western blot kit and preparation method thereof |
WO2012178187A1 (en) | 2011-06-23 | 2012-12-27 | Paul Yager | Reagent patterning in capillarity-based analyzers and associated systems and methods |
US20150168394A1 (en) | 2011-09-16 | 2015-06-18 | Credo Biomedical Pte Ltd | Molecular diagnostic assay device and method of use |
WO2013051889A2 (en) * | 2011-10-06 | 2013-04-11 | 광주과학기술원 | Membrane sensor enabled with sequential change of reaction condition with single sample injection |
KR101896496B1 (en) * | 2011-12-13 | 2018-09-11 | (주)미코바이오메드 | Glycosylated hemoglobin sensor strip, glycosylated hemoglobin measurement device and method for glycosylated hemoglobin measurement |
JP5541748B2 (en) * | 2012-03-29 | 2014-07-09 | 株式会社Lsiメディエンス | Immunochromatographic test device using avidin-biotin linked labeling reagent and use thereof |
US9903856B2 (en) | 2012-05-22 | 2018-02-27 | Korea University Research And Business Foundation | Optical biosensor |
JP5728453B2 (en) * | 2012-09-27 | 2015-06-03 | 富士フイルム株式会社 | Chromatograph method and chromatograph kit |
CN105050720A (en) | 2013-01-22 | 2015-11-11 | 华盛顿大学商业化中心 | Sequential delivery of fluid volumes and associated devices, systems and methods |
CN105556307B (en) | 2013-04-15 | 2019-07-05 | 南洋理工大学 | The bioassay of electrochemistry lateral flow and biosensor |
KR101489195B1 (en) * | 2014-01-28 | 2015-02-04 | 강원대학교산학협력단 | Sheet used for calibrating fluorescent signal measured by instrument for measuring fluorescent signal and manufacturing method thereof |
US20150044707A1 (en) * | 2014-02-18 | 2015-02-12 | Melinda Sanders | At-Home Blood Pregnancy Test Kit |
US10001449B2 (en) | 2014-12-15 | 2018-06-19 | Church & Dwight Co., Inc. | Systems, devices and methods for a hydroscopic based lateral flow assay |
GB2535998A (en) * | 2015-02-27 | 2016-09-07 | Intelligent Fingerprinting Ltd | A device for receiving and analysing a sample |
KR101705480B1 (en) * | 2015-08-19 | 2017-02-09 | 고려대학교 산학협력단 | Ultra-high Sensitivity Biosensor based on 2-Dimensional Chromatography |
CN108369228B (en) | 2015-12-18 | 2020-11-17 | 富士胶片株式会社 | Immunochromatography kit |
KR101788221B1 (en) * | 2015-12-29 | 2017-10-19 | 광주과학기술원 | Membrane Strip Sensor With Swelling Member |
KR101998795B1 (en) * | 2016-05-23 | 2019-07-10 | 고려대학교 세종산학협력단 | Immunological biosensor and sensor system including the same |
US10191046B2 (en) * | 2016-05-23 | 2019-01-29 | Se-Hwan Paek | Immunobiosensor and sensor system including the same |
WO2018097796A1 (en) * | 2016-11-23 | 2018-05-31 | Fajs Luka | Device and method to determine or quantify the presence of an analyte molecule |
US10799861B2 (en) * | 2016-11-24 | 2020-10-13 | Korea University Research And Business Foundation, Sejong Campus | Biochemical-immunological hybrid biosensor and sensor system including the same |
CN106596532B (en) * | 2016-11-24 | 2019-07-23 | 桂林理工大学 | A kind of detection method of simple alkaline phosphatase activities |
KR101863315B1 (en) | 2017-02-24 | 2018-06-29 | 계명대학교 산학협력단 | Automatic injection type diagnostic kit equipment |
US11543410B2 (en) * | 2017-09-01 | 2023-01-03 | University Of Cincinnati | Methods and applications of on-chip dried or lyophilized chemiluminescence substrate reagents |
KR101984582B1 (en) * | 2017-09-06 | 2019-05-31 | (주)맥솔루션 | Bio-diagnostic kits using nanomagnetic particles and frequency mixing magnetic reader including the same |
DK3489686T3 (en) * | 2017-11-22 | 2021-03-22 | Dewact Labs GmbH | Method and device for distinguishing between viral and bacterial infections |
KR101960634B1 (en) * | 2018-04-19 | 2019-07-04 | 고려대학교 세종산학협력단 | Single-channel, hybrid biosensor and sensor system including the same |
KR102224541B1 (en) * | 2019-03-29 | 2021-03-05 | 연세대학교 산학협력단 | Bio-electrode, chronoamperometry device, immunoassay device and method using the same |
JP7304649B2 (en) * | 2019-05-24 | 2023-07-07 | ソル バイオ コーポレーション | Affinity separation system and method using switchable attachment reactions |
KR102323361B1 (en) * | 2019-05-24 | 2021-11-09 | 솔바이오 주식회사 | Affinity-based separation system and method using switch-like binding reaction |
CN110243776A (en) * | 2019-06-21 | 2019-09-17 | 福建中医药大学 | Improve reaction microenvironment using lauryl sodium sulfate and carries out that silver ion is qualitative and the detection method of quantitative detection |
CN110531070A (en) * | 2019-08-31 | 2019-12-03 | 东南大学 | A kind of vertical current test strips |
JP6714256B1 (en) * | 2019-12-18 | 2020-06-24 | 株式会社イムノセンス | Electrochemical lateral flow immunoassay method, sensor thereof and method of manufacturing the same |
CN111521823A (en) * | 2020-05-17 | 2020-08-11 | 曹馨元 | Detection kit and detection device for target protein/peptide |
KR102492978B1 (en) * | 2020-07-31 | 2023-02-01 | 주식회사 큐에스택 | Diagnosis Strip |
KR102530556B1 (en) * | 2020-11-26 | 2023-05-09 | 바디텍메드(주) | Diagnostic cartridge for immunodiagnosis and diagnostic device and system using the same |
CN113884481B (en) * | 2021-09-29 | 2022-05-03 | 华南师范大学 | Dry bipolar electrochemical luminescence chip and application thereof in immunodetection |
KR102592018B1 (en) * | 2021-10-08 | 2023-10-20 | 한국과학기술원 | Detachable Absorbent Paper Structure with Adjustable Filter and Reaction Speed |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723345A (en) * | 1994-06-28 | 1998-03-03 | Mochida Pharmaceutical Co., Ltd. | Method and device for specific binding assay |
US6187598B1 (en) * | 1987-04-27 | 2001-02-13 | Conopco Inc. | Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents |
USRE37437E1 (en) * | 1984-12-15 | 2001-11-06 | Dade Behring Marburg, Gmbh | Sheet-like diagnostic device |
US6352862B1 (en) * | 1989-02-17 | 2002-03-05 | Unilever Patent Holdings B.V. | Analytical test device for imuno assays and methods of using same |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5275785A (en) * | 1987-10-30 | 1994-01-04 | Unilever Patent Holdings B.V. | Test device for detecting an analyte in a liquid sample |
US5264180A (en) * | 1989-03-16 | 1993-11-23 | Chemtrak, Inc. | Mobile reagents in an analyte assay in a self-contained apparatus |
US5648274A (en) * | 1991-05-29 | 1997-07-15 | Smithkline Diagnostics, Inc. | Competitive immunoassay device |
EP0525723B1 (en) * | 1991-07-29 | 1997-05-14 | Mochida Pharmaceutical Co., Ltd. | Process and device for specific binding assay |
US5726010A (en) * | 1991-07-31 | 1998-03-10 | Idexx Laboratories, Inc. | Reversible flow chromatographic binding assay |
JPH08262023A (en) * | 1991-12-30 | 1996-10-11 | Fujirebio Inc | Strip analyzer |
US6156270A (en) | 1992-05-21 | 2000-12-05 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
US5837546A (en) * | 1993-08-24 | 1998-11-17 | Metrika, Inc. | Electronic assay device and method |
GB9324310D0 (en) * | 1993-11-26 | 1994-01-12 | Univ Birmingham | Liquid transfer device |
JPH0875748A (en) * | 1994-06-28 | 1996-03-22 | Mochida Pharmaceut Co Ltd | Method and apparatus for analyzing specific bond |
US5753517A (en) | 1996-03-29 | 1998-05-19 | University Of British Columbia | Quantitative immunochromatographic assays |
JP3859027B2 (en) * | 1996-12-18 | 2006-12-20 | 日本化薬株式会社 | Method for measuring specific substances in nipple discharge |
US5939252A (en) * | 1997-05-09 | 1999-08-17 | Lennon; Donald J. | Detachable-element assay device |
US6222619B1 (en) | 1997-09-18 | 2001-04-24 | University Of Utah Research Foundation | Diagnostic device and method |
US6087184A (en) * | 1997-11-10 | 2000-07-11 | Beckman Coulter, Inc. | Opposable-element chromatographic assay device for detection of analytes |
US5997817A (en) * | 1997-12-05 | 1999-12-07 | Roche Diagnostics Corporation | Electrochemical biosensor test strip |
JPH11248705A (en) * | 1998-03-06 | 1999-09-17 | Dainippon Printing Co Ltd | Allergen testing kit |
ATE331219T1 (en) * | 1999-08-06 | 2006-07-15 | Pharmacia Diagnostics Ab | ANALYTICAL METHOD AND APPARATUS |
KR100348351B1 (en) | 2000-05-24 | 2002-08-09 | 주식회사 바이오디지트 | Electrochemical membrane strip biosensor |
JP4043699B2 (en) * | 2000-07-07 | 2008-02-06 | 浜松ホトニクス株式会社 | Immunochromatographic test tool and immunochromatographic test piece measuring device |
KR100455907B1 (en) * | 2001-07-28 | 2004-11-12 | 주식회사 아이센스 | Non-separation type enzyme-immunsensor using parallel microporous electrodes |
-
2004
- 2004-04-20 US US10/827,884 patent/US7300802B2/en active Active
- 2004-04-21 DE DE602004015585T patent/DE602004015585D1/en not_active Expired - Lifetime
- 2004-04-21 EP EP04728716A patent/EP1618383B1/en not_active Expired - Lifetime
- 2004-04-21 WO PCT/KR2004/000914 patent/WO2004097419A1/en active Application Filing
- 2004-04-21 AT AT04728716T patent/ATE403869T1/en not_active IP Right Cessation
- 2004-04-21 CN CNA2004800111598A patent/CN1781022A/en active Pending
- 2004-04-21 JP JP2006507812A patent/JP4546462B2/en not_active Expired - Fee Related
- 2004-04-23 KR KR1020040028440A patent/KR100599420B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE37437E1 (en) * | 1984-12-15 | 2001-11-06 | Dade Behring Marburg, Gmbh | Sheet-like diagnostic device |
US6187598B1 (en) * | 1987-04-27 | 2001-02-13 | Conopco Inc. | Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents |
US6352862B1 (en) * | 1989-02-17 | 2002-03-05 | Unilever Patent Holdings B.V. | Analytical test device for imuno assays and methods of using same |
US5723345A (en) * | 1994-06-28 | 1998-03-03 | Mochida Pharmaceutical Co., Ltd. | Method and device for specific binding assay |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10082507B2 (en) | 2003-12-31 | 2018-09-25 | President And Fellows Of Harvard College | Assay device and method |
US9116148B2 (en) | 2004-01-26 | 2015-08-25 | President And Fellows Of Harvard College | Fluid delivery system and method |
US10048252B2 (en) | 2004-01-26 | 2018-08-14 | President And Fellows Of Harvard College | Fluid delivery system and method |
JP4689379B2 (en) * | 2005-07-12 | 2011-05-25 | 旭化成株式会社 | Biochemical analyzer |
JP2007024549A (en) * | 2005-07-12 | 2007-02-01 | Asahi Kasei Corp | Biochemical analyzer |
CN101183108A (en) * | 2007-10-16 | 2008-05-21 | 李红玉 | Colloidal gold test paper for detecting trace quantity oxygenize low density lipoprotein by indirect competition method |
EP2460009A1 (en) * | 2009-07-31 | 2012-06-06 | Invisible Sentinel, Inc. | Device for detection of antigens and uses thereof |
US10705084B2 (en) | 2009-07-31 | 2020-07-07 | Invisible Sentinel, Inc. | Analyte detection devices, multiplex and tabletop devices for detection of analytes, and uses thereof |
US8476082B2 (en) | 2009-07-31 | 2013-07-02 | Invisible Sentinel, Inc. | Device for detection of target molecules and uses thereof |
US9341624B2 (en) | 2009-07-31 | 2016-05-17 | Invisible Sentinel, Inc. | Device for detection of target molecules and uses thereof |
EP2460009A4 (en) * | 2009-07-31 | 2012-12-26 | Invisible Sentinel Inc | Device for detection of antigens and uses thereof |
US9475049B2 (en) | 2009-07-31 | 2016-10-25 | Invisible Sentinel, Inc. | Analyte detection devices, multiplex and tabletop devices for detection of analyte, and uses thereof |
US9816984B2 (en) | 2009-07-31 | 2017-11-14 | Invisible Sentinel, Inc. | Device for detection of target molecules and uses thereof |
US10495638B2 (en) | 2009-10-09 | 2019-12-03 | Invisible Sentinel, Inc. | Device for detection of analytes and uses thereof |
US9557330B2 (en) | 2009-10-09 | 2017-01-31 | Invisible Sentinel, Inc. | Device for detection of analytes and uses thereof |
US10712340B2 (en) | 2012-01-20 | 2020-07-14 | Ortho-Clinical Diagnostics, Inc. | Assay device having controllable sample size |
US11921107B2 (en) | 2012-01-20 | 2024-03-05 | Ortho-Clinical Diagnostics, Inc. | Assay device having controllable sample size |
US9823240B2 (en) | 2012-03-09 | 2017-11-21 | Invisible Sentinel, Inc. | Methods and compositions for detecting multiple analytes with a single signal |
US10018626B2 (en) | 2012-03-09 | 2018-07-10 | Invisible Sentinel, Inc. | Methods and compositions for detecting multiple analytes with a single signal |
US9347938B2 (en) | 2012-03-09 | 2016-05-24 | Invisible Sentinel, Inc. | Methods for detecting multiple analytes with a single signal |
US10732177B2 (en) | 2012-03-09 | 2020-08-04 | Invisible Sentinel, Inc. | Methods and compositions for detecting multiple analytes with a single signal |
US9255866B2 (en) | 2013-03-13 | 2016-02-09 | Opko Diagnostics, Llc | Mixing of fluids in fluidic systems |
US10684201B2 (en) | 2013-03-13 | 2020-06-16 | Opko Diagnostics, Llc | Mixing of fluids in fluidic systems |
US9588027B2 (en) | 2013-03-13 | 2017-03-07 | UPKO Diagnostics, LLC | Mixing of fluids in fluidic systems |
WO2016062788A1 (en) | 2014-10-24 | 2016-04-28 | Ait Austrian Institute Of Technology Gmbh | Microfluidic chip for biological analysis |
US11253853B2 (en) | 2014-12-12 | 2022-02-22 | Opko Diagnostics, Llc | Fluidic systems comprising an incubation channel, including fluidic systems formed by molding |
US10279345B2 (en) | 2014-12-12 | 2019-05-07 | Opko Diagnostics, Llc | Fluidic systems comprising an incubation channel, including fluidic systems formed by molding |
GB2571763A (en) * | 2018-03-08 | 2019-09-11 | Sumitomo Chemical Co | Enzyme-amplified lateral flow device |
Also Published As
Publication number | Publication date |
---|---|
US20040214253A1 (en) | 2004-10-28 |
KR100599420B1 (en) | 2006-07-10 |
CN1781022A (en) | 2006-05-31 |
EP1618383B1 (en) | 2008-08-06 |
EP1618383A1 (en) | 2006-01-25 |
EP1618383A4 (en) | 2007-01-10 |
ATE403869T1 (en) | 2008-08-15 |
DE602004015585D1 (en) | 2008-09-18 |
KR20040093048A (en) | 2004-11-04 |
JP4546462B2 (en) | 2010-09-15 |
JP2006524815A (en) | 2006-11-02 |
US7300802B2 (en) | 2007-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1618383B1 (en) | Membrane strip biosensor system for point-of-care testing | |
Cho et al. | Chemiluminometric enzyme-linked immunosorbent assays (ELISA)-on-a-chip biosensor based on cross-flow chromatography | |
US5939272A (en) | Non-competitive threshold ligand-receptor assays | |
JP3009155B2 (en) | Immunochromatographic analysis method | |
US5149629A (en) | Coulometric assay system | |
US5028535A (en) | Threshold ligand-receptor assay | |
US7312028B2 (en) | Highly cost-effective analytical device for performing immunoassays with ultra high sensitivity | |
US20080019866A1 (en) | Lab-On-A-Chip For An On-The-Spot Analysis And Signal Detection Methods For The Same | |
WO1995006240A9 (en) | Novel disposable electronic assay device | |
JPS6250663A (en) | Multi-zone analyzing testing tool with zone in which detectable signal concentrate | |
EP0722563A1 (en) | Novel disposable electronic assay device | |
Cho et al. | Semiquantitative, bar code version of immunochromatographic assay system for human serum albumin as model analyte | |
JPS61292060A (en) | Analyzing element | |
JP2642342B2 (en) | Solid phase diffusion test method | |
JPH0346561A (en) | Method, reagent and test strip for detecting article to be analyzed | |
KR101916608B1 (en) | Biochemical-immunological hybrid biosensor and sensor system including the same | |
EP1597559A2 (en) | Method and apparatus for detecting an analyte | |
EP1540343B1 (en) | Method for the elimination of interferences in immunochromatographic assays | |
CA2198948A1 (en) | Quantitative detection of analytes on immunochromatographic strips | |
JPH06242114A (en) | Method and device for enzyme-immunity type measurement of material to be analyzed from solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004728716 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4701/DELNP/2005 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20048111598 Country of ref document: CN Ref document number: 2006507812 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004728716 Country of ref document: EP |